SC and TM development occur synchronously, with each expected to influence the other’s development (Thomson et al., 2021; Libby et al., 2003). It has characteristics of both blood and lymphatic vessels, making it a hybrid endothelial structure (Aspelund et al., 2014; Park et al., 2014; Kizhatil et al., 2014; Balasubramanian et al., 2024). During early SC development (P2.5–4.5), tip cell (TC) formation, sprouting, and cellular interactions give rise to a rudimentary SC (rSC) structure. TM-derived signals are essential for guiding SC development, maintaining SC health/integrity, and regulating IOP. VEGFA/KDR [VEGFR2], VEGFC/FLT4 [VEGFR3], ANGPT1/TEK, SVEP1/TEK) utilize ligands produced by TM cells (Thomson et al., 2021; Aspelund et al., 2014; Kizhatil et al., 2014; Thomson et al., 2017).